nodes	percent_of_prediction	percent_of_DWPC	metapath
Temsirolimus—CYP3A7—Simvastatin—atherosclerosis	0.0562	0.0807	CbGbCtD
Temsirolimus—CYP3A7-CYP3A51P—Simvastatin—atherosclerosis	0.0562	0.0807	CbGbCtD
Temsirolimus—CYP3A7—Lovastatin—atherosclerosis	0.055	0.079	CbGbCtD
Temsirolimus—CYP3A7-CYP3A51P—Lovastatin—atherosclerosis	0.055	0.079	CbGbCtD
Temsirolimus—CYP3A5—Rosuvastatin—atherosclerosis	0.0454	0.0651	CbGbCtD
Temsirolimus—CYP3A5—Simvastatin—atherosclerosis	0.0422	0.0606	CbGbCtD
Temsirolimus—CYP3A5—Lovastatin—atherosclerosis	0.0413	0.0593	CbGbCtD
Temsirolimus—CYP3A5—Pravastatin—atherosclerosis	0.0413	0.0593	CbGbCtD
Temsirolimus—CYP2D6—Niacin—atherosclerosis	0.0327	0.047	CbGbCtD
Temsirolimus—ABCB1—Ezetimibe—atherosclerosis	0.0295	0.0424	CbGbCtD
Temsirolimus—ABCB1—Simvastatin—atherosclerosis	0.0274	0.0394	CbGbCtD
Temsirolimus—ABCB1—Pravastatin—atherosclerosis	0.0269	0.0386	CbGbCtD
Temsirolimus—ABCB1—Lovastatin—atherosclerosis	0.0269	0.0386	CbGbCtD
Temsirolimus—CYP2D6—Simvastatin—atherosclerosis	0.0259	0.0371	CbGbCtD
Temsirolimus—CYP2D6—Lovastatin—atherosclerosis	0.0253	0.0363	CbGbCtD
Temsirolimus—CYP2D6—Pravastatin—atherosclerosis	0.0253	0.0363	CbGbCtD
Temsirolimus—CYP3A4—Ezetimibe—atherosclerosis	0.0177	0.0254	CbGbCtD
Temsirolimus—CYP3A4—Rosuvastatin—atherosclerosis	0.0177	0.0254	CbGbCtD
Temsirolimus—CYP3A4—Simvastatin—atherosclerosis	0.0164	0.0236	CbGbCtD
Temsirolimus—CYP3A4—Lovastatin—atherosclerosis	0.0161	0.0231	CbGbCtD
Temsirolimus—CYP3A4—Pravastatin—atherosclerosis	0.0161	0.0231	CbGbCtD
Temsirolimus—MTOR—leg—atherosclerosis	0.0081	0.199	CbGeAlD
Temsirolimus—MTOR—hindlimb—atherosclerosis	0.00724	0.178	CbGeAlD
Temsirolimus—MTOR—appendage—atherosclerosis	0.00621	0.153	CbGeAlD
Temsirolimus—MTOR—blood vessel—atherosclerosis	0.00346	0.085	CbGeAlD
Temsirolimus—MTOR—connective tissue—atherosclerosis	0.00177	0.0436	CbGeAlD
Temsirolimus—FKBP1A—connective tissue—atherosclerosis	0.00159	0.0392	CbGeAlD
Temsirolimus—MTOR—cardiovascular system—atherosclerosis	0.00154	0.0379	CbGeAlD
Temsirolimus—FKBP1A—cardiovascular system—atherosclerosis	0.00139	0.0341	CbGeAlD
Temsirolimus—MTOR—adipose tissue—atherosclerosis	0.00136	0.0335	CbGeAlD
Temsirolimus—FKBP1A—adipose tissue—atherosclerosis	0.00122	0.0301	CbGeAlD
Temsirolimus—CYP3A7—liver—atherosclerosis	0.00106	0.0261	CbGeAlD
Temsirolimus—MTOR—liver—atherosclerosis	0.000953	0.0235	CbGeAlD
Temsirolimus—CYP3A7-CYP3A51P—liver—atherosclerosis	0.000902	0.0222	CbGeAlD
Temsirolimus—FKBP1A—liver—atherosclerosis	0.000858	0.0211	CbGeAlD
Temsirolimus—ABCB1—blood vessel—atherosclerosis	0.000719	0.0177	CbGeAlD
Temsirolimus—Face oedema—Niacin—atherosclerosis	0.000701	0.00444	CcSEcCtD
Temsirolimus—Gastritis—Simvastatin—atherosclerosis	0.000699	0.00443	CcSEcCtD
Temsirolimus—Rhinitis—Rosuvastatin—atherosclerosis	0.000691	0.00438	CcSEcCtD
Temsirolimus—Pharyngitis—Rosuvastatin—atherosclerosis	0.000684	0.00434	CcSEcCtD
Temsirolimus—Upper respiratory tract infection—Ezetimibe—atherosclerosis	0.000666	0.00422	CcSEcCtD
Temsirolimus—Dry skin—Niacin—atherosclerosis	0.000665	0.00422	CcSEcCtD
Temsirolimus—Bronchitis—Simvastatin—atherosclerosis	0.000657	0.00416	CcSEcCtD
Temsirolimus—Dry skin—Pravastatin—atherosclerosis	0.000655	0.00415	CcSEcCtD
Temsirolimus—Stevens-Johnson syndrome—Lovastatin—atherosclerosis	0.000645	0.00409	CcSEcCtD
Temsirolimus—Infestation NOS—Ezetimibe—atherosclerosis	0.000639	0.00405	CcSEcCtD
Temsirolimus—Infestation—Ezetimibe—atherosclerosis	0.000639	0.00405	CcSEcCtD
Temsirolimus—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.000635	0.00402	CcSEcCtD
Temsirolimus—Urinary tract infection—Lovastatin—atherosclerosis	0.000633	0.00401	CcSEcCtD
Temsirolimus—Abdominal distension—Niacin—atherosclerosis	0.000631	0.004	CcSEcCtD
Temsirolimus—Alanine aminotransferase increased—Pravastatin—atherosclerosis	0.00063	0.00399	CcSEcCtD
Temsirolimus—Influenza—Niacin—atherosclerosis	0.000627	0.00398	CcSEcCtD
Temsirolimus—Dysphagia—Niacin—atherosclerosis	0.000627	0.00398	CcSEcCtD
Temsirolimus—Abdominal distension—Pravastatin—atherosclerosis	0.000622	0.00394	CcSEcCtD
Temsirolimus—Influenza—Pravastatin—atherosclerosis	0.000617	0.00391	CcSEcCtD
Temsirolimus—Sinusitis—Lovastatin—atherosclerosis	0.000611	0.00387	CcSEcCtD
Temsirolimus—Depression—Simvastatin—atherosclerosis	0.000607	0.00385	CcSEcCtD
Temsirolimus—Mental disorder—Rosuvastatin—atherosclerosis	0.000604	0.00383	CcSEcCtD
Temsirolimus—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.000604	0.00383	CcSEcCtD
Temsirolimus—Bronchitis—Niacin—atherosclerosis	0.000603	0.00382	CcSEcCtD
Temsirolimus—Sinusitis—Ezetimibe—atherosclerosis	0.000599	0.0038	CcSEcCtD
Temsirolimus—Dysuria—Pravastatin—atherosclerosis	0.000577	0.00366	CcSEcCtD
Temsirolimus—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.000574	0.00364	CcSEcCtD
Temsirolimus—Sinusitis—Simvastatin—atherosclerosis	0.000571	0.00362	CcSEcCtD
Temsirolimus—Pharyngitis—Ezetimibe—atherosclerosis	0.000569	0.00361	CcSEcCtD
Temsirolimus—Oedema peripheral—Ezetimibe—atherosclerosis	0.000565	0.00358	CcSEcCtD
Temsirolimus—Connective tissue disorder—Ezetimibe—atherosclerosis	0.000563	0.00357	CcSEcCtD
Temsirolimus—Weight decreased—Pravastatin—atherosclerosis	0.000559	0.00354	CcSEcCtD
Temsirolimus—Erythema multiforme—Lovastatin—atherosclerosis	0.000553	0.0035	CcSEcCtD
Temsirolimus—Depression—Pravastatin—atherosclerosis	0.000549	0.00348	CcSEcCtD
Temsirolimus—Angioedema—Rosuvastatin—atherosclerosis	0.000549	0.00348	CcSEcCtD
Temsirolimus—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.000546	0.00346	CcSEcCtD
Temsirolimus—Stomatitis—Niacin—atherosclerosis	0.000545	0.00346	CcSEcCtD
Temsirolimus—Erythema multiforme—Ezetimibe—atherosclerosis	0.000542	0.00344	CcSEcCtD
Temsirolimus—Urinary tract infection—Pravastatin—atherosclerosis	0.000535	0.00339	CcSEcCtD
Temsirolimus—CYP3A5—adipose tissue—atherosclerosis	0.000532	0.0131	CbGeAlD
Temsirolimus—Chills—Lovastatin—atherosclerosis	0.000524	0.00332	CcSEcCtD
Temsirolimus—Cough—Rosuvastatin—atherosclerosis	0.000524	0.00332	CcSEcCtD
Temsirolimus—Angiopathy—Ezetimibe—atherosclerosis	0.00052	0.0033	CcSEcCtD
Temsirolimus—Immune system disorder—Ezetimibe—atherosclerosis	0.000518	0.00328	CcSEcCtD
Temsirolimus—Erythema multiforme—Simvastatin—atherosclerosis	0.000517	0.00328	CcSEcCtD
Temsirolimus—Mediastinal disorder—Ezetimibe—atherosclerosis	0.000517	0.00328	CcSEcCtD
Temsirolimus—Sinusitis—Pravastatin—atherosclerosis	0.000517	0.00327	CcSEcCtD
Temsirolimus—Arthralgia—Rosuvastatin—atherosclerosis	0.000511	0.00324	CcSEcCtD
Temsirolimus—Myalgia—Rosuvastatin—atherosclerosis	0.000511	0.00324	CcSEcCtD
Temsirolimus—Rhinitis—Niacin—atherosclerosis	0.000503	0.00319	CcSEcCtD
Temsirolimus—Mental disorder—Ezetimibe—atherosclerosis	0.000502	0.00318	CcSEcCtD
Temsirolimus—Malnutrition—Ezetimibe—atherosclerosis	0.000499	0.00316	CcSEcCtD
Temsirolimus—Erythema—Ezetimibe—atherosclerosis	0.000499	0.00316	CcSEcCtD
Temsirolimus—Dysgeusia—Lovastatin—atherosclerosis	0.000498	0.00316	CcSEcCtD
Temsirolimus—Rhinitis—Pravastatin—atherosclerosis	0.000495	0.00314	CcSEcCtD
Temsirolimus—Oedema peripheral—Niacin—atherosclerosis	0.000495	0.00313	CcSEcCtD
Temsirolimus—Back pain—Lovastatin—atherosclerosis	0.000492	0.00312	CcSEcCtD
Temsirolimus—Pharyngitis—Pravastatin—atherosclerosis	0.000491	0.00311	CcSEcCtD
Temsirolimus—Chills—Simvastatin—atherosclerosis	0.000491	0.00311	CcSEcCtD
Temsirolimus—Infection—Rosuvastatin—atherosclerosis	0.000487	0.00309	CcSEcCtD
Temsirolimus—Back pain—Ezetimibe—atherosclerosis	0.000483	0.00306	CcSEcCtD
Temsirolimus—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000481	0.00305	CcSEcCtD
Temsirolimus—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00048	0.00304	CcSEcCtD
Temsirolimus—Mental disorder—Simvastatin—atherosclerosis	0.000479	0.00304	CcSEcCtD
Temsirolimus—Erythema—Simvastatin—atherosclerosis	0.000476	0.00302	CcSEcCtD
Temsirolimus—Eye disorder—Niacin—atherosclerosis	0.000469	0.00297	CcSEcCtD
Temsirolimus—Erythema multiforme—Pravastatin—atherosclerosis	0.000467	0.00296	CcSEcCtD
Temsirolimus—Dysgeusia—Simvastatin—atherosclerosis	0.000466	0.00295	CcSEcCtD
Temsirolimus—Angioedema—Lovastatin—atherosclerosis	0.000465	0.00295	CcSEcCtD
Temsirolimus—Anaemia—Ezetimibe—atherosclerosis	0.000461	0.00292	CcSEcCtD
Temsirolimus—Cardiac disorder—Pravastatin—atherosclerosis	0.000459	0.00291	CcSEcCtD
Temsirolimus—Angioedema—Ezetimibe—atherosclerosis	0.000456	0.00289	CcSEcCtD
Temsirolimus—Angiopathy—Niacin—atherosclerosis	0.000455	0.00289	CcSEcCtD
Temsirolimus—Leukopenia—Lovastatin—atherosclerosis	0.000455	0.00289	CcSEcCtD
Temsirolimus—Chills—Niacin—atherosclerosis	0.00045	0.00286	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000446	0.00283	CcSEcCtD
Temsirolimus—Chills—Pravastatin—atherosclerosis	0.000443	0.00281	CcSEcCtD
Temsirolimus—Insomnia—Rosuvastatin—atherosclerosis	0.000443	0.00281	CcSEcCtD
Temsirolimus—Anaemia—Simvastatin—atherosclerosis	0.00044	0.00279	CcSEcCtD
Temsirolimus—Erythema—Niacin—atherosclerosis	0.000437	0.00277	CcSEcCtD
Temsirolimus—Malnutrition—Niacin—atherosclerosis	0.000437	0.00277	CcSEcCtD
Temsirolimus—Cough—Ezetimibe—atherosclerosis	0.000435	0.00276	CcSEcCtD
Temsirolimus—Angioedema—Simvastatin—atherosclerosis	0.000435	0.00276	CcSEcCtD
Temsirolimus—Chest pain—Lovastatin—atherosclerosis	0.000433	0.00275	CcSEcCtD
Temsirolimus—Arthralgia—Lovastatin—atherosclerosis	0.000433	0.00275	CcSEcCtD
Temsirolimus—Myalgia—Lovastatin—atherosclerosis	0.000433	0.00275	CcSEcCtD
Temsirolimus—Anxiety—Lovastatin—atherosclerosis	0.000432	0.00274	CcSEcCtD
Temsirolimus—Hypertension—Ezetimibe—atherosclerosis	0.000431	0.00273	CcSEcCtD
Temsirolimus—Leukopenia—Simvastatin—atherosclerosis	0.000426	0.0027	CcSEcCtD
Temsirolimus—Myalgia—Ezetimibe—atherosclerosis	0.000425	0.00269	CcSEcCtD
Temsirolimus—Chest pain—Ezetimibe—atherosclerosis	0.000425	0.00269	CcSEcCtD
Temsirolimus—Arthralgia—Ezetimibe—atherosclerosis	0.000425	0.00269	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000422	0.00267	CcSEcCtD
Temsirolimus—Dysgeusia—Pravastatin—atherosclerosis	0.000421	0.00267	CcSEcCtD
Temsirolimus—Pain—Rosuvastatin—atherosclerosis	0.000419	0.00266	CcSEcCtD
Temsirolimus—Constipation—Rosuvastatin—atherosclerosis	0.000419	0.00266	CcSEcCtD
Temsirolimus—Anaphylactic shock—Lovastatin—atherosclerosis	0.000415	0.00263	CcSEcCtD
Temsirolimus—Infection—Lovastatin—atherosclerosis	0.000413	0.00262	CcSEcCtD
Temsirolimus—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000407	0.00258	CcSEcCtD
Temsirolimus—Thrombocytopenia—Lovastatin—atherosclerosis	0.000407	0.00258	CcSEcCtD
Temsirolimus—Chest pain—Simvastatin—atherosclerosis	0.000405	0.00257	CcSEcCtD
Temsirolimus—Myalgia—Simvastatin—atherosclerosis	0.000405	0.00257	CcSEcCtD
Temsirolimus—Arthralgia—Simvastatin—atherosclerosis	0.000405	0.00257	CcSEcCtD
Temsirolimus—Infection—Ezetimibe—atherosclerosis	0.000405	0.00257	CcSEcCtD
Temsirolimus—Anxiety—Simvastatin—atherosclerosis	0.000404	0.00256	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000401	0.00254	CcSEcCtD
Temsirolimus—Nervous system disorder—Ezetimibe—atherosclerosis	0.000399	0.00253	CcSEcCtD
Temsirolimus—Angioedema—Niacin—atherosclerosis	0.000399	0.00253	CcSEcCtD
Temsirolimus—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000399	0.00253	CcSEcCtD
Temsirolimus—Anaemia—Pravastatin—atherosclerosis	0.000398	0.00252	CcSEcCtD
Temsirolimus—Anorexia—Lovastatin—atherosclerosis	0.000396	0.00251	CcSEcCtD
Temsirolimus—Skin disorder—Ezetimibe—atherosclerosis	0.000396	0.00251	CcSEcCtD
Temsirolimus—Angioedema—Pravastatin—atherosclerosis	0.000393	0.00249	CcSEcCtD
Temsirolimus—Leukopenia—Niacin—atherosclerosis	0.000391	0.00248	CcSEcCtD
Temsirolimus—Anaphylactic shock—Simvastatin—atherosclerosis	0.000388	0.00246	CcSEcCtD
Temsirolimus—Oedema—Simvastatin—atherosclerosis	0.000388	0.00246	CcSEcCtD
Temsirolimus—Abdominal pain—Rosuvastatin—atherosclerosis	0.000387	0.00246	CcSEcCtD
Temsirolimus—Infection—Simvastatin—atherosclerosis	0.000386	0.00245	CcSEcCtD
Temsirolimus—Leukopenia—Pravastatin—atherosclerosis	0.000385	0.00244	CcSEcCtD
Temsirolimus—Cough—Niacin—atherosclerosis	0.000381	0.00242	CcSEcCtD
Temsirolimus—Thrombocytopenia—Simvastatin—atherosclerosis	0.00038	0.00241	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000378	0.0024	CcSEcCtD
Temsirolimus—Insomnia—Lovastatin—atherosclerosis	0.000376	0.00238	CcSEcCtD
Temsirolimus—Cough—Pravastatin—atherosclerosis	0.000375	0.00238	CcSEcCtD
Temsirolimus—CYP3A5—liver—atherosclerosis	0.000373	0.00919	CbGeAlD
Temsirolimus—Arthralgia—Niacin—atherosclerosis	0.000372	0.00236	CcSEcCtD
Temsirolimus—Myalgia—Niacin—atherosclerosis	0.000372	0.00236	CcSEcCtD
Temsirolimus—Hypertension—Pravastatin—atherosclerosis	0.000371	0.00235	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000371	0.00235	CcSEcCtD
Temsirolimus—Anorexia—Simvastatin—atherosclerosis	0.00037	0.00235	CcSEcCtD
Temsirolimus—Dyspnoea—Lovastatin—atherosclerosis	0.00037	0.00235	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000369	0.00234	CcSEcCtD
Temsirolimus—Insomnia—Ezetimibe—atherosclerosis	0.000368	0.00234	CcSEcCtD
Temsirolimus—Myalgia—Pravastatin—atherosclerosis	0.000366	0.00232	CcSEcCtD
Temsirolimus—Chest pain—Pravastatin—atherosclerosis	0.000366	0.00232	CcSEcCtD
Temsirolimus—Arthralgia—Pravastatin—atherosclerosis	0.000366	0.00232	CcSEcCtD
Temsirolimus—Anxiety—Pravastatin—atherosclerosis	0.000365	0.00231	CcSEcCtD
Temsirolimus—Dyspnoea—Ezetimibe—atherosclerosis	0.000363	0.0023	CcSEcCtD
Temsirolimus—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000361	0.00229	CcSEcCtD
Temsirolimus—Decreased appetite—Lovastatin—atherosclerosis	0.000361	0.00229	CcSEcCtD
Temsirolimus—Fatigue—Lovastatin—atherosclerosis	0.000358	0.00227	CcSEcCtD
Temsirolimus—Oedema—Niacin—atherosclerosis	0.000357	0.00226	CcSEcCtD
Temsirolimus—Anaphylactic shock—Niacin—atherosclerosis	0.000357	0.00226	CcSEcCtD
Temsirolimus—Pain—Lovastatin—atherosclerosis	0.000355	0.00225	CcSEcCtD
Temsirolimus—Constipation—Lovastatin—atherosclerosis	0.000355	0.00225	CcSEcCtD
Temsirolimus—Decreased appetite—Ezetimibe—atherosclerosis	0.000354	0.00224	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000354	0.00224	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000352	0.00223	CcSEcCtD
Temsirolimus—Asthenia—Rosuvastatin—atherosclerosis	0.000352	0.00223	CcSEcCtD
Temsirolimus—Insomnia—Simvastatin—atherosclerosis	0.000351	0.00223	CcSEcCtD
Temsirolimus—Oedema—Pravastatin—atherosclerosis	0.000351	0.00223	CcSEcCtD
Temsirolimus—Anaphylactic shock—Pravastatin—atherosclerosis	0.000351	0.00223	CcSEcCtD
Temsirolimus—Fatigue—Ezetimibe—atherosclerosis	0.000351	0.00223	CcSEcCtD
Temsirolimus—Infection—Pravastatin—atherosclerosis	0.000349	0.00221	CcSEcCtD
Temsirolimus—Constipation—Ezetimibe—atherosclerosis	0.000348	0.00221	CcSEcCtD
Temsirolimus—Pain—Ezetimibe—atherosclerosis	0.000348	0.00221	CcSEcCtD
Temsirolimus—Pruritus—Rosuvastatin—atherosclerosis	0.000347	0.0022	CcSEcCtD
Temsirolimus—Skin disorder—Niacin—atherosclerosis	0.000346	0.0022	CcSEcCtD
Temsirolimus—Dyspnoea—Simvastatin—atherosclerosis	0.000346	0.0022	CcSEcCtD
Temsirolimus—Thrombocytopenia—Pravastatin—atherosclerosis	0.000344	0.00218	CcSEcCtD
Temsirolimus—Anorexia—Niacin—atherosclerosis	0.00034	0.00216	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00034	0.00215	CcSEcCtD
Temsirolimus—Decreased appetite—Simvastatin—atherosclerosis	0.000338	0.00214	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000335	0.00213	CcSEcCtD
Temsirolimus—Diarrhoea—Rosuvastatin—atherosclerosis	0.000335	0.00213	CcSEcCtD
Temsirolimus—Fatigue—Simvastatin—atherosclerosis	0.000335	0.00212	CcSEcCtD
Temsirolimus—Anorexia—Pravastatin—atherosclerosis	0.000335	0.00212	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000333	0.00211	CcSEcCtD
Temsirolimus—Pain—Simvastatin—atherosclerosis	0.000332	0.00211	CcSEcCtD
Temsirolimus—Constipation—Simvastatin—atherosclerosis	0.000332	0.00211	CcSEcCtD
Temsirolimus—Body temperature increased—Lovastatin—atherosclerosis	0.000328	0.00208	CcSEcCtD
Temsirolimus—Abdominal pain—Lovastatin—atherosclerosis	0.000328	0.00208	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000325	0.00206	CcSEcCtD
Temsirolimus—Dizziness—Rosuvastatin—atherosclerosis	0.000324	0.00205	CcSEcCtD
Temsirolimus—Insomnia—Niacin—atherosclerosis	0.000323	0.00204	CcSEcCtD
Temsirolimus—Abdominal pain—Ezetimibe—atherosclerosis	0.000322	0.00204	CcSEcCtD
Temsirolimus—Body temperature increased—Ezetimibe—atherosclerosis	0.000322	0.00204	CcSEcCtD
Temsirolimus—ABCB1—cardiovascular system—atherosclerosis	0.000321	0.00789	CbGeAlD
Temsirolimus—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00032	0.00203	CcSEcCtD
Temsirolimus—Dyspnoea—Niacin—atherosclerosis	0.000318	0.00202	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000318	0.00201	CcSEcCtD
Temsirolimus—Insomnia—Pravastatin—atherosclerosis	0.000318	0.00201	CcSEcCtD
Temsirolimus—Somnolence—Niacin—atherosclerosis	0.000317	0.00201	CcSEcCtD
Temsirolimus—Dyspnoea—Pravastatin—atherosclerosis	0.000313	0.00198	CcSEcCtD
Temsirolimus—Decreased appetite—Niacin—atherosclerosis	0.00031	0.00197	CcSEcCtD
Temsirolimus—Rash—Rosuvastatin—atherosclerosis	0.000309	0.00196	CcSEcCtD
Temsirolimus—Dermatitis—Rosuvastatin—atherosclerosis	0.000309	0.00196	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Niacin—atherosclerosis	0.000308	0.00195	CcSEcCtD
Temsirolimus—Body temperature increased—Simvastatin—atherosclerosis	0.000307	0.00195	CcSEcCtD
Temsirolimus—Abdominal pain—Simvastatin—atherosclerosis	0.000307	0.00195	CcSEcCtD
Temsirolimus—Headache—Rosuvastatin—atherosclerosis	0.000307	0.00195	CcSEcCtD
Temsirolimus—Hypersensitivity—Lovastatin—atherosclerosis	0.000306	0.00194	CcSEcCtD
Temsirolimus—Decreased appetite—Pravastatin—atherosclerosis	0.000305	0.00194	CcSEcCtD
Temsirolimus—Pain—Niacin—atherosclerosis	0.000305	0.00193	CcSEcCtD
Temsirolimus—Fatigue—Pravastatin—atherosclerosis	0.000303	0.00192	CcSEcCtD
Temsirolimus—Constipation—Pravastatin—atherosclerosis	0.0003	0.0019	CcSEcCtD
Temsirolimus—Pain—Pravastatin—atherosclerosis	0.0003	0.0019	CcSEcCtD
Temsirolimus—Hypersensitivity—Ezetimibe—atherosclerosis	0.0003	0.0019	CcSEcCtD
Temsirolimus—Asthenia—Lovastatin—atherosclerosis	0.000298	0.00189	CcSEcCtD
Temsirolimus—Pruritus—Lovastatin—atherosclerosis	0.000294	0.00186	CcSEcCtD
Temsirolimus—Asthenia—Ezetimibe—atherosclerosis	0.000292	0.00185	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Niacin—atherosclerosis	0.000292	0.00185	CcSEcCtD
Temsirolimus—Nausea—Rosuvastatin—atherosclerosis	0.000291	0.00185	CcSEcCtD
Temsirolimus—Pruritus—Ezetimibe—atherosclerosis	0.000288	0.00183	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000287	0.00182	CcSEcCtD
Temsirolimus—Hypersensitivity—Simvastatin—atherosclerosis	0.000286	0.00181	CcSEcCtD
Temsirolimus—Diarrhoea—Lovastatin—atherosclerosis	0.000284	0.0018	CcSEcCtD
Temsirolimus—ABCB1—adipose tissue—atherosclerosis	0.000283	0.00696	CbGeAlD
Temsirolimus—Abdominal pain—Niacin—atherosclerosis	0.000282	0.00179	CcSEcCtD
Temsirolimus—Body temperature increased—Niacin—atherosclerosis	0.000282	0.00179	CcSEcCtD
Temsirolimus—CYP3A4—liver—atherosclerosis	0.00028	0.0069	CbGeAlD
Temsirolimus—Asthenia—Simvastatin—atherosclerosis	0.000279	0.00177	CcSEcCtD
Temsirolimus—Diarrhoea—Ezetimibe—atherosclerosis	0.000279	0.00177	CcSEcCtD
Temsirolimus—Body temperature increased—Pravastatin—atherosclerosis	0.000278	0.00176	CcSEcCtD
Temsirolimus—Abdominal pain—Pravastatin—atherosclerosis	0.000278	0.00176	CcSEcCtD
Temsirolimus—CYP2D6—liver—atherosclerosis	0.000276	0.00679	CbGeAlD
Temsirolimus—Pruritus—Simvastatin—atherosclerosis	0.000275	0.00174	CcSEcCtD
Temsirolimus—Dizziness—Lovastatin—atherosclerosis	0.000275	0.00174	CcSEcCtD
Temsirolimus—Dizziness—Ezetimibe—atherosclerosis	0.000269	0.00171	CcSEcCtD
Temsirolimus—Diarrhoea—Simvastatin—atherosclerosis	0.000266	0.00168	CcSEcCtD
Temsirolimus—Vomiting—Lovastatin—atherosclerosis	0.000264	0.00167	CcSEcCtD
Temsirolimus—Hypersensitivity—Niacin—atherosclerosis	0.000263	0.00167	CcSEcCtD
Temsirolimus—Rash—Lovastatin—atherosclerosis	0.000262	0.00166	CcSEcCtD
Temsirolimus—Dermatitis—Lovastatin—atherosclerosis	0.000262	0.00166	CcSEcCtD
Temsirolimus—Headache—Lovastatin—atherosclerosis	0.00026	0.00165	CcSEcCtD
Temsirolimus—Vomiting—Ezetimibe—atherosclerosis	0.000259	0.00164	CcSEcCtD
Temsirolimus—Hypersensitivity—Pravastatin—atherosclerosis	0.000259	0.00164	CcSEcCtD
Temsirolimus—Dizziness—Simvastatin—atherosclerosis	0.000257	0.00163	CcSEcCtD
Temsirolimus—Rash—Ezetimibe—atherosclerosis	0.000257	0.00163	CcSEcCtD
Temsirolimus—Dermatitis—Ezetimibe—atherosclerosis	0.000257	0.00163	CcSEcCtD
Temsirolimus—Asthenia—Niacin—atherosclerosis	0.000256	0.00162	CcSEcCtD
Temsirolimus—Headache—Ezetimibe—atherosclerosis	0.000255	0.00162	CcSEcCtD
Temsirolimus—Pruritus—Niacin—atherosclerosis	0.000252	0.0016	CcSEcCtD
Temsirolimus—Asthenia—Pravastatin—atherosclerosis	0.000252	0.0016	CcSEcCtD
Temsirolimus—Pruritus—Pravastatin—atherosclerosis	0.000248	0.00157	CcSEcCtD
Temsirolimus—Vomiting—Simvastatin—atherosclerosis	0.000247	0.00157	CcSEcCtD
Temsirolimus—Nausea—Lovastatin—atherosclerosis	0.000247	0.00156	CcSEcCtD
Temsirolimus—Rash—Simvastatin—atherosclerosis	0.000245	0.00155	CcSEcCtD
Temsirolimus—Dermatitis—Simvastatin—atherosclerosis	0.000245	0.00155	CcSEcCtD
Temsirolimus—Diarrhoea—Niacin—atherosclerosis	0.000244	0.00155	CcSEcCtD
Temsirolimus—Headache—Simvastatin—atherosclerosis	0.000243	0.00154	CcSEcCtD
Temsirolimus—Nausea—Ezetimibe—atherosclerosis	0.000242	0.00153	CcSEcCtD
Temsirolimus—Diarrhoea—Pravastatin—atherosclerosis	0.00024	0.00152	CcSEcCtD
Temsirolimus—Dizziness—Niacin—atherosclerosis	0.000236	0.0015	CcSEcCtD
Temsirolimus—Dizziness—Pravastatin—atherosclerosis	0.000232	0.00147	CcSEcCtD
Temsirolimus—Nausea—Simvastatin—atherosclerosis	0.000231	0.00146	CcSEcCtD
Temsirolimus—Vomiting—Niacin—atherosclerosis	0.000227	0.00144	CcSEcCtD
Temsirolimus—Rash—Niacin—atherosclerosis	0.000225	0.00143	CcSEcCtD
Temsirolimus—Dermatitis—Niacin—atherosclerosis	0.000225	0.00142	CcSEcCtD
Temsirolimus—Headache—Niacin—atherosclerosis	0.000223	0.00142	CcSEcCtD
Temsirolimus—Vomiting—Pravastatin—atherosclerosis	0.000223	0.00142	CcSEcCtD
Temsirolimus—Rash—Pravastatin—atherosclerosis	0.000221	0.0014	CcSEcCtD
Temsirolimus—Dermatitis—Pravastatin—atherosclerosis	0.000221	0.0014	CcSEcCtD
Temsirolimus—Headache—Pravastatin—atherosclerosis	0.00022	0.00139	CcSEcCtD
Temsirolimus—Nausea—Niacin—atherosclerosis	0.000212	0.00134	CcSEcCtD
Temsirolimus—Nausea—Pravastatin—atherosclerosis	0.000209	0.00132	CcSEcCtD
Temsirolimus—ABCB1—liver—atherosclerosis	0.000198	0.00488	CbGeAlD
Temsirolimus—MTOR—Disease—CAV1—atherosclerosis	1.84e-05	0.000175	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	1.84e-05	0.000175	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PLG—atherosclerosis	1.84e-05	0.000175	CbGpPWpGaD
Temsirolimus—MTOR—Disease—APOA1—atherosclerosis	1.84e-05	0.000175	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CYP27A1—atherosclerosis	1.83e-05	0.000173	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—SERPINE1—atherosclerosis	1.82e-05	0.000173	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	1.79e-05	0.00017	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	1.79e-05	0.00017	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—STAT3—atherosclerosis	1.77e-05	0.000168	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—MAPK3—atherosclerosis	1.77e-05	0.000168	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—NAMPT—atherosclerosis	1.75e-05	0.000166	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—SOCS3—atherosclerosis	1.74e-05	0.000166	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—LIPC—atherosclerosis	1.74e-05	0.000165	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—NOS3—atherosclerosis	1.74e-05	0.000165	CbGpPWpGaD
Temsirolimus—MTOR—Disease—NOS2—atherosclerosis	1.73e-05	0.000165	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PLA2G2A—atherosclerosis	1.73e-05	0.000164	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—APOA2—atherosclerosis	1.73e-05	0.000164	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ALOX5AP—atherosclerosis	1.73e-05	0.000164	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ALOX15—atherosclerosis	1.73e-05	0.000164	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—APOC3—atherosclerosis	1.73e-05	0.000164	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CYP27A1—atherosclerosis	1.72e-05	0.000163	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—LDLR—atherosclerosis	1.72e-05	0.000163	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ABCG5—atherosclerosis	1.71e-05	0.000162	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ABCG8—atherosclerosis	1.7e-05	0.000161	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—LTA4H—atherosclerosis	1.7e-05	0.000161	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—MAPK3—atherosclerosis	1.69e-05	0.00016	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MMP3—atherosclerosis	1.69e-05	0.00016	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IGF2—atherosclerosis	1.68e-05	0.000159	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CETP—atherosclerosis	1.68e-05	0.000159	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	1.67e-05	0.000159	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—LPA—atherosclerosis	1.65e-05	0.000157	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—TGFB1—atherosclerosis	1.64e-05	0.000156	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	1.63e-05	0.000155	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	1.63e-05	0.000155	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—APOA2—atherosclerosis	1.63e-05	0.000155	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ALOX15—atherosclerosis	1.63e-05	0.000155	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—APOB—atherosclerosis	1.63e-05	0.000155	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ABCG5—atherosclerosis	1.61e-05	0.000153	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—SCARB1—atherosclerosis	1.61e-05	0.000153	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—HMOX1—atherosclerosis	1.61e-05	0.000152	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—EDN1—atherosclerosis	1.6e-05	0.000152	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—BGN—atherosclerosis	1.6e-05	0.000152	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CCL5—atherosclerosis	1.59e-05	0.000151	CbGpPWpGaD
Temsirolimus—MTOR—Disease—INS—atherosclerosis	1.59e-05	0.000151	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—APOA5—atherosclerosis	1.58e-05	0.00015	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—LPA—atherosclerosis	1.56e-05	0.000148	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—LPL—atherosclerosis	1.56e-05	0.000148	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CXCL8—atherosclerosis	1.54e-05	0.000146	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—APOB—atherosclerosis	1.54e-05	0.000146	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PLA2G1B—atherosclerosis	1.52e-05	0.000145	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—HMGCR—atherosclerosis	1.52e-05	0.000144	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PRKCG—atherosclerosis	1.51e-05	0.000144	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.51e-05	0.000143	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—BGN—atherosclerosis	1.51e-05	0.000143	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—GSTM1—atherosclerosis	1.5e-05	0.000142	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—APOA5—atherosclerosis	1.49e-05	0.000142	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—SPP1—atherosclerosis	1.47e-05	0.00014	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ALOX5—atherosclerosis	1.47e-05	0.00014	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—LPL—atherosclerosis	1.47e-05	0.000139	CbGpPWpGaD
Temsirolimus—MTOR—Disease—SERPINE1—atherosclerosis	1.46e-05	0.000139	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IFNG—atherosclerosis	1.44e-05	0.000137	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	1.44e-05	0.000136	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—GPX1—atherosclerosis	1.43e-05	0.000136	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.42e-05	0.000135	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—CD36—atherosclerosis	1.39e-05	0.000132	CbGpPWpGaD
Temsirolimus—MTOR—Disease—NOS3—atherosclerosis	1.39e-05	0.000132	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—MMP9—atherosclerosis	1.39e-05	0.000132	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ALOX5—atherosclerosis	1.39e-05	0.000132	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—NFKB1—atherosclerosis	1.38e-05	0.000131	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PDGFB—atherosclerosis	1.36e-05	0.000129	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—MAPK8—atherosclerosis	1.35e-05	0.000129	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—ABCA1—atherosclerosis	1.35e-05	0.000128	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.34e-05	0.000128	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—AGT—atherosclerosis	1.33e-05	0.000126	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—MTHFR—atherosclerosis	1.32e-05	0.000126	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—NAMPT—atherosclerosis	1.32e-05	0.000125	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—LIPC—atherosclerosis	1.31e-05	0.000125	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—APOC3—atherosclerosis	1.3e-05	0.000124	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—LEP—atherosclerosis	1.3e-05	0.000124	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—APOE—atherosclerosis	1.3e-05	0.000124	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PPARA—atherosclerosis	1.3e-05	0.000123	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—LDLR—atherosclerosis	1.3e-05	0.000123	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—IL6—atherosclerosis	1.29e-05	0.000123	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CAV1—atherosclerosis	1.29e-05	0.000123	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—APOA1—atherosclerosis	1.29e-05	0.000122	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL1B—atherosclerosis	1.29e-05	0.000122	CbGpPWpGaD
Temsirolimus—MTOR—Disease—PTGS2—atherosclerosis	1.28e-05	0.000121	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CETP—atherosclerosis	1.27e-05	0.00012	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—FABP4—atherosclerosis	1.26e-05	0.00012	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—LCAT—atherosclerosis	1.26e-05	0.00012	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—AGT—atherosclerosis	1.26e-05	0.000119	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—VEGFA—atherosclerosis	1.25e-05	0.000119	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—ESR1—atherosclerosis	1.24e-05	0.000118	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—NAMPT—atherosclerosis	1.24e-05	0.000118	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	1.24e-05	0.000118	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—APOA4—atherosclerosis	1.24e-05	0.000118	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—STAT3—atherosclerosis	1.24e-05	0.000118	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—LIPC—atherosclerosis	1.24e-05	0.000117	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—IL6—atherosclerosis	1.24e-05	0.000117	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—APOE—atherosclerosis	1.23e-05	0.000117	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—F2—atherosclerosis	1.23e-05	0.000117	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—APOC3—atherosclerosis	1.23e-05	0.000117	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—LDLR—atherosclerosis	1.22e-05	0.000116	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—CAV1—atherosclerosis	1.22e-05	0.000116	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.22e-05	0.000116	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—APOA1—atherosclerosis	1.22e-05	0.000116	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—SCARB1—atherosclerosis	1.21e-05	0.000115	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—NFKB1—atherosclerosis	1.2e-05	0.000114	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CETP—atherosclerosis	1.19e-05	0.000113	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—AKT1—atherosclerosis	1.19e-05	0.000113	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—MAPK3—atherosclerosis	1.18e-05	0.000112	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—MAPK8—atherosclerosis	1.18e-05	0.000112	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PIK3CG—atherosclerosis	1.18e-05	0.000112	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—HMOX1—atherosclerosis	1.16e-05	0.00011	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—TGFB1—atherosclerosis	1.15e-05	0.000109	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—HMGCR—atherosclerosis	1.14e-05	0.000109	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—AKT1—atherosclerosis	1.14e-05	0.000109	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—SCARB1—atherosclerosis	1.14e-05	0.000108	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—AKT1—atherosclerosis	1.14e-05	0.000108	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.13e-05	0.000107	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	1.12e-05	0.000107	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—INS—atherosclerosis	1.11e-05	0.000106	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—APOB—atherosclerosis	1.11e-05	0.000106	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PIK3CG—atherosclerosis	1.11e-05	0.000105	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CCL2—atherosclerosis	1.1e-05	0.000104	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GSTM1—atherosclerosis	1.08e-05	0.000103	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—HMGCR—atherosclerosis	1.08e-05	0.000102	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—STAT3—atherosclerosis	1.08e-05	0.000102	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IGF1—atherosclerosis	1.08e-05	0.000102	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PPARG—atherosclerosis	1.07e-05	0.000102	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—APOA2—atherosclerosis	1.07e-05	0.000101	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.07e-05	0.000101	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.07e-05	0.000101	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.07e-05	0.000101	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—LPL—atherosclerosis	1.06e-05	0.000101	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.05e-05	0.0001	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—INS—atherosclerosis	1.05e-05	9.98e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GPX1—atherosclerosis	1.04e-05	9.83e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—MAPK3—atherosclerosis	1.03e-05	9.78e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—SERPINE1—atherosclerosis	1.02e-05	9.71e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ABCA1—atherosclerosis	1.02e-05	9.69e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—LPA—atherosclerosis	1.02e-05	9.66e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CD36—atherosclerosis	1.01e-05	9.57e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—STAT3—atherosclerosis	9.95e-06	9.45e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—BGN—atherosclerosis	9.86e-06	9.36e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—NOS3—atherosclerosis	9.77e-06	9.27e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—APOA5—atherosclerosis	9.76e-06	9.26e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—ALB—atherosclerosis	9.64e-06	9.15e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ABCA1—atherosclerosis	9.62e-06	9.13e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—MTHFR—atherosclerosis	9.55e-06	9.07e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—MAPK3—atherosclerosis	9.5e-06	9.03e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	9.39e-06	8.92e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PPARA—atherosclerosis	9.37e-06	8.9e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—TGFB1—atherosclerosis	9.22e-06	8.76e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—NOS3—atherosclerosis	9.22e-06	8.75e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—AGT—atherosclerosis	9.08e-06	8.62e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ALOX5—atherosclerosis	9.07e-06	8.61e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—APOE—atherosclerosis	8.89e-06	8.45e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CAV1—atherosclerosis	8.81e-06	8.37e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—APOA1—atherosclerosis	8.79e-06	8.35e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—HMOX1—atherosclerosis	8.75e-06	8.31e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CXCL8—atherosclerosis	8.66e-06	8.23e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—IL6—atherosclerosis	8.65e-06	8.22e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PTGS2—atherosclerosis	8.43e-06	8.01e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—APOB—atherosclerosis	8.39e-06	7.96e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—HMOX1—atherosclerosis	8.25e-06	7.83e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GSTM1—atherosclerosis	8.16e-06	7.75e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—NAMPT—atherosclerosis	8.14e-06	7.73e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—LIPC—atherosclerosis	8.08e-06	7.68e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—APOC3—atherosclerosis	8.03e-06	7.63e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PIK3CG—atherosclerosis	8.03e-06	7.62e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—LPL—atherosclerosis	8.01e-06	7.6e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—LDLR—atherosclerosis	7.99e-06	7.58e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—AKT1—atherosclerosis	7.98e-06	7.58e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—APOB—atherosclerosis	7.9e-06	7.5e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MMP9—atherosclerosis	7.84e-06	7.44e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GPX1—atherosclerosis	7.81e-06	7.42e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CETP—atherosclerosis	7.8e-06	7.41e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—NFKB1—atherosclerosis	7.75e-06	7.36e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PPARG—atherosclerosis	7.75e-06	7.36e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GSTM1—atherosclerosis	7.69e-06	7.3e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MAPK8—atherosclerosis	7.62e-06	7.24e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CD36—atherosclerosis	7.61e-06	7.22e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—INS—atherosclerosis	7.6e-06	7.22e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—LPL—atherosclerosis	7.55e-06	7.17e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL6—atherosclerosis	7.53e-06	7.15e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—SCARB1—atherosclerosis	7.47e-06	7.09e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GPX1—atherosclerosis	7.36e-06	6.99e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—MTHFR—atherosclerosis	7.21e-06	6.85e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CD36—atherosclerosis	7.17e-06	6.81e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PPARA—atherosclerosis	7.07e-06	6.72e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—HMGCR—atherosclerosis	7.05e-06	6.7e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—VEGFA—atherosclerosis	7.04e-06	6.68e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—STAT3—atherosclerosis	6.97e-06	6.62e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—ALB—atherosclerosis	6.97e-06	6.62e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—IL6—atherosclerosis	6.95e-06	6.6e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—AKT1—atherosclerosis	6.94e-06	6.59e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—AGT—atherosclerosis	6.85e-06	6.5e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—MTHFR—atherosclerosis	6.79e-06	6.45e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—APOE—atherosclerosis	6.71e-06	6.37e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PPARA—atherosclerosis	6.67e-06	6.33e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—NOS3—atherosclerosis	6.66e-06	6.33e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MAPK3—atherosclerosis	6.66e-06	6.32e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CAV1—atherosclerosis	6.65e-06	6.31e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—APOA1—atherosclerosis	6.63e-06	6.3e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TGFB1—atherosclerosis	6.46e-06	6.13e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—AGT—atherosclerosis	6.46e-06	6.13e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—AKT1—atherosclerosis	6.41e-06	6.09e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—APOE—atherosclerosis	6.32e-06	6.01e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ABCA1—atherosclerosis	6.29e-06	5.97e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CAV1—atherosclerosis	6.27e-06	5.95e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—APOA1—atherosclerosis	6.25e-06	5.94e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PTGS2—atherosclerosis	6.09e-06	5.79e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PIK3CG—atherosclerosis	6.06e-06	5.75e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PPARG—atherosclerosis	5.85e-06	5.55e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—INS—atherosclerosis	5.73e-06	5.44e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PIK3CG—atherosclerosis	5.71e-06	5.42e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PPARG—atherosclerosis	5.51e-06	5.23e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—INS—atherosclerosis	5.4e-06	5.13e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—HMOX1—atherosclerosis	5.39e-06	5.12e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ALB—atherosclerosis	5.26e-06	4.99e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—APOB—atherosclerosis	5.17e-06	4.91e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—NOS3—atherosclerosis	5.03e-06	4.77e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GSTM1—atherosclerosis	5.03e-06	4.77e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ALB—atherosclerosis	4.95e-06	4.7e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—LPL—atherosclerosis	4.93e-06	4.68e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IL6—atherosclerosis	4.87e-06	4.62e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GPX1—atherosclerosis	4.81e-06	4.57e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—NOS3—atherosclerosis	4.74e-06	4.5e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CD36—atherosclerosis	4.69e-06	4.45e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PTGS2—atherosclerosis	4.6e-06	4.37e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—AKT1—atherosclerosis	4.49e-06	4.26e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—MTHFR—atherosclerosis	4.44e-06	4.22e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PPARA—atherosclerosis	4.36e-06	4.14e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PTGS2—atherosclerosis	4.33e-06	4.12e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—AKT1—atherosclerosis	4.24e-06	4.02e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—AGT—atherosclerosis	4.22e-06	4.01e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—APOE—atherosclerosis	4.14e-06	3.93e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CAV1—atherosclerosis	4.1e-06	3.89e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—APOA1—atherosclerosis	4.09e-06	3.88e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PIK3CG—atherosclerosis	3.73e-06	3.54e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PPARG—atherosclerosis	3.6e-06	3.42e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—INS—atherosclerosis	3.53e-06	3.35e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ALB—atherosclerosis	3.24e-06	3.08e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—NOS3—atherosclerosis	3.1e-06	2.94e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—AKT1—atherosclerosis	3.06e-06	2.91e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PTGS2—atherosclerosis	2.83e-06	2.69e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—AKT1—atherosclerosis	2.31e-06	2.19e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—AKT1—atherosclerosis	2.18e-06	2.07e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—AKT1—atherosclerosis	1.42e-06	1.35e-05	CbGpPWpGaD
